Clinical Trials Directory

Trials / Completed

CompletedNCT03703557

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer

Feasibility Study on the Possibility of Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Institut Curie · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

To ascertain the possibilities to isolate the breast cancer olfactive signature.

Detailed description

Patient recruitment during the first surgery consultation in Curie Institute. Odor sampling (non-invasive) with an odor-sensing polymer (Sorbstar® polymer developed especially for the trace level analysis), on: * The hands, before and after surgical excision of the tumor (friction of the hands) * The diseased breast, before and after surgical excision of the tumor (via a compress positioned on the breast for 1 night) * The tumor, during the surgical procedure (odor collection over a tumor sample). Each patient will be her own witness, before and after surgical excision, in an attempt to isolate the chemical signature tracks of breast cancer. The samples after surgery will be made after healing and before implementation of a treatment (chemotherapy and / or radiotherapy).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSorbstar®Thermodesorption method coupled with full two-dimensional gas chromatography and mass spectrometry.
DIAGNOSTIC_TESTOdour samplingAnalyzed by the dogs of Curie Institute at the training centers

Timeline

Start date
2018-07-25
Primary completion
2019-09-20
Completion
2020-09-20
First posted
2018-10-12
Last updated
2020-12-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03703557. Inclusion in this directory is not an endorsement.